ClinicalTrials.Veeva

Menu

Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Terminated

Conditions

Hypertension

Treatments

Behavioral: Weekly check-in

Study type

Interventional

Funder types

Other

Identifiers

NCT04577131
HM20019041

Details and patient eligibility

About

The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.

Full description

High blood pressure is very common and increases risk of heart, kidney, brain, and eye disease. It is important to diagnose and treat high blood pressure to reduce risk of these complications. Getting blood pressure checked only when someone sees a doctor is not the best way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking blood pressure at home gives a better idea of whether someone's blood pressure is normal or too high.

As part of their usual blood pressure monitoring, participants will be given an Omron 3 series or 5 series blood pressure monitor which has been cleared by the US Food and Drug Administration and validated to meet accuracy and performance requirements. For one month, participants will monitor their blood pressure once a day and then return the device to the clinic at the end of the study. Participants will text their blood pressure result to the American Heart Association's Check, Change, Control (CCC) secure online tracker.

As part of the research study, participants will also be randomized to either receive or not receive weekly check-in phone calls from a pharmacist to review their blood pressures and the number of times they tested in that week. Approximately 50 individuals will participate in this study. Participation in this study will last 1 month.

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age and older
  • Uncontrolled hypertension (BP > 130/80 mm Hg)

Exclusion criteria

  • non-English speaking patients
  • patients without a mobile phone or texting capability

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1 participants in 2 patient groups

With check-ins
Experimental group
Description:
Daily blood pressure monitoring with weekly check-ins
Treatment:
Behavioral: Weekly check-in
Without check-ins
No Intervention group
Description:
Daily blood pressure monitoring without weekly check-ins

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems